烟雾病临床治疗及术后并发症预测研究进展
Advances in Clinical Treatment and Postoperative Complication Prediction of Moyamoya Disease
DOI: 10.12677/ACM.2022.1291198, PDF,    国家自然科学基金支持
作者: 王丹丹：西安医学院，陕西 西安；空军军医大学西京医院，麻醉与围术期医学科，陕西 西安；空军军医大学西京医院，重症医学科，陕西 西安；张昊鹏：空军军医大学西京医院，麻醉与围术期医学科，陕西 西安；贺亚龙, 林 伟：空军军医大学西京医院，神经外科，陕西 西安；苏斌虓：空军军医大学西京医院，重症医学科，陕西 西安
关键词: 烟雾病；临床治疗；围手术期；Moyamoya Disease； Clinical Treatment； Perioperative Period
摘要: 烟雾病是一种严重困扰成人尤其是儿童发育的慢性脑血管疾病。临床现有治疗方法多以手术为主，辅以内科及中医治疗。但术后并发症的高发病率以及难预料性仍给予临床工作一定的困难。本文回顾了近年来国内外烟雾病临床治疗方法及预后评价，发现术后并发症的预测应作为烟雾病临床治疗的一个重要方向。围手术期的管理及监测有望成为提前预防及干预术后并发症的重要措施。
Abstract: Moyamoya disease is a chronic cerebrovascular disease that seriously affects the development of adults, especially children. The existing clinical treatment methods are mostly surgery, supple-mented by internal medicine and traditional Chinese medicine. However, the high incidence and unpredictability of postoperative complications still make clinical work difficult. This paper re-viewed the clinical treatment methods and prognosis evaluation of moyamoya disease at home and abroad in recent years, and found that the prediction of postoperative complications should be an important direction of clinical treatment of moyamoya disease. Perioperative management and monitoring are expected to be an important measure for early prevention and intervention of postoperative complications.
文章引用：王丹丹, 张昊鹏, 贺亚龙, 林伟, 苏斌虓. 烟雾病临床治疗及术后并发症预测研究进展[J]. 临床医学进展, 2022, 12(9): 8319-8324. https://doi.org/10.12677/ACM.2022.1291198

参考文献

[1] Suzuki, J. and Kodama, N. (1983) Moyamoya Disease—A Review. Stroke, 14, 104-109. [Google Scholar] [CrossRef] 
[2] Shang, S., Zhou, D., Ya, J., et al. (2020) Progress in Moyamoya Disease. Neurosurgical Review, 43, 371-382. [Google Scholar] [CrossRef] [PubMed]
[3] Sun, Y., Zhou, G., Feng, J., et al. (2021) Incidence and Preva-lence of Moyamoya Disease in Urban China: A Nationwide Retrospective Cohort Study. Stroke and Vascular Neurology, 6, e000909. [Google Scholar] [CrossRef] [PubMed]
[4] Hoshino, H., Izawa, Y. and Suzuki, N. (2012) Epidemiological Features of Moyamoya Disease in Japan. Neurologia Medico-Chirurgica, 52, 295-298. [Google Scholar] [CrossRef] [PubMed]
[5] Nisiewicz, M.J., Roberts, J.M., Dobbs, M.R., et al. (2020) High Preva-lence of Moyamoya Syndrome in Appalachia. Cerebrovascular Diseases, 49, 516-521. [Google Scholar] [CrossRef] [PubMed]
[6] Ahn, I.M., Park, D.H., Hann, H.J., et al. (2014) Incidence, Prevalence, and Survival of Moyamoya Disease in Korea: A Nationwide, Population-Based Study. Stroke, 45, 1090-1095. [Google Scholar] [CrossRef] 
[7] Suzuki, J. and Takaku, A. (1969) Cerebrovascular “Mo-yamoya” Disease. Disease Showing Abnormal Net-Like Vessels in Base of Brain. Archives of Neurology, 20, 288-299. [Google Scholar] [CrossRef] [PubMed]
[8] Onozuka, D., Hagihara, A., Nishimura, K., et al. (2016) Prehospital Antiplatelet Use and Functional Status on Admission of Patients with Non-Haemorrhagic Moyamoya Disease: A Nationwide Retrospective Cohort Study (J-Aspect Study). BMJ Open, 6, e009942. [Google Scholar] [CrossRef] [PubMed]
[9] Mayeku, J. and Lopez-Gonzalez, M.A. (2020) Current Surgical Options for Moyamoya Disease. Cureus, 12, e11332. [Google Scholar] [CrossRef] [PubMed]
[10] Ando, T., Shimada, Y., Fujiwara, S., et al. (2020) Revascularisation Surgery Improves Cognition in Adult Patients with Moyamoya Disease. Journal of Neurology, Neurosurgery, & Psychi-atry, 91, 332-334. [Google Scholar] [CrossRef] [PubMed]
[11] Ang, P., Cai, H., Luo, R., et al. (2021) Assessment of Surgical Outcomes in Children and Adult Ischemic Moyamoya Disease and Its Relationship with the Pre-Infarction Cerebral Per-fusion Status. Turkish Neurosurgery, 32, 43-51. [Google Scholar] [CrossRef] 
[12] Taniguchi, M., Taki, T., Tsuzuki, T., et al. (2007) EC-IC Bypass Using the Distal Stump of the Superficial Temporal Artery as an Additional Collateral Source of Blood Flow in Patients with Moyamoya Disease. Acta Neurochirurgica, 149, 393-398. [Google Scholar] [CrossRef] [PubMed]
[13] Egashira, Y., Yoshimura, S., Enomoto, Y., et al. (2018) Sin-gle-Stage Direct Revascularization for Bilateral Anterior Cerebral Artery Regions in Pediatric Moyamoya Disease: A Technical Note. World Neurosurgery, 118, 324-328. [Google Scholar] [CrossRef] [PubMed]
[14] Hayashi, T., Shirane, R. and Tominaga, T. (2009) Additional Surgery for Postoperative Ischemic Symptoms in Patients with Moyamoya Disease: The Effectiveness of Occipital Ar-tery-Posterior Cerebral Artery Bypass with an Indirect Procedure: Technical Case Report. Neurosurgery, 64, E195-E196. [Google Scholar] [CrossRef] 
[15] Matsushima, Y. and Inaba, Y. (1984) Moyamoya Disease in Children and Its Surgical Treatment. Introduction of a New Surgical Procedure and Its Follow-Up Angio-grams. Childs Brain, 11, 155-170. [Google Scholar] [CrossRef] [PubMed]
[16] Tu, Y.-K., Liu, H.-M., Kuo, M.-F., Wang, P.-J., et al. (1997) Combined Encephalo-Arterio-Synangiosis and Encephalo-Myo-Synangiosis in the Treatment of Moyamoya Disease. Clinical Neu-rology and Neurosurgery, 99, S118-S22. [Google Scholar] [CrossRef] 
[17] Bang, J.S., Kwon, O.K., Kim, J.E., et al. (2012) Quantitative Angiographic Comparison with the Osiris Program between the Direct and Indirect Revascularization Modalities in Adult Moyamoya Disease. Neurosurgery, 70, 625-633. [Google Scholar] [CrossRef] 
[18] Kawaguchi, T., Fujita, S., Hosoda, K., et al. (1996) Multiple Burr-Hole Operation for Adult Moyamoya Disease. Journal of Neurosurgery, 84, 468-476. [Google Scholar] [CrossRef] [PubMed]
[19] Jeon, J.P., Kim, J.E., Cho, W.S., et al. (2018) Meta-Analysis of the Surgical Outcomes of Symptomatic Moyamoya Disease in Adults. Journal of Neurosurgery, 128, 793-799. [Google Scholar] [CrossRef] 
[20] Canavero, I., Vetrano, I., Zedde, M., et al. (2021) Clinical Man-agement of Moyamoya Patients. Journal of Clinical Medicine, 10, Article No. 3628. [Google Scholar] [CrossRef] [PubMed]
[21] Qian, Y., Huang, B., Hu, Z., et al. (2020) Analysis of Factors Related to Cerebral Infarction after Direct Bypass Surgery in Adults with Moyamoya Disease. Cerebrovascular Diseases, 49, 55-61. [Google Scholar] [CrossRef] [PubMed]
[22] Choi, S., Sung, J., Jo, E., et al. (2021) Language Treatment Effects on Communicative Abilities and Working Memory in Korean-Speaking Agrammatic Broca’s Aphasia Caused by Mo-yamoya disease: Phase II Evidence from a Case Study. Neurocase, 27, 297-307. [Google Scholar] [CrossRef] [PubMed]
[23] Shlobin, N., Frankel, H., Lam, S. (2021) Failures in Revas-cularization for Pediatric Moyamoya Disease and Syndrome: A Scoping Review. World Neurosurgery, 149, 204-214.e1. [Google Scholar] [CrossRef] [PubMed]
[24] Case, D., Kumpe, D., Roark, C., et al. (2020) Neuroangiography: Review of Anatomy, Periprocedural Management, Technique, and Tips. Seminars in Interventional Radiology, 37, 166-174. [Google Scholar] [CrossRef] [PubMed]
[25] Huguenard, A., Guerriero, R., Tomko, S., et al. (2021) Immediate Postoperative Electroencephalography Monitoring in Pediatric Moyamoya Disease and Syndrome. Pediatric Neurology, 118, 40-45. [Google Scholar] [CrossRef] [PubMed]
[26] Kashiwazaki, D., Akioka, N., Kuwayama, N., et al. (2017) Berlin Grading System Can Stratify the Onset and Predict Perioperative Complications in Adult Moyamoya Disease. Neurosurgery, 81, 986-991. [Google Scholar] [CrossRef] [PubMed]
[27] Uchino, H., Kuroda, S., Hirata, K., et al. (2012) Predictors and Clinical Features of Postoperative Hyperperfusion after Surgical Revascularization for Moyamoya Disease: A Serial Single Pho-ton Emission CT/Positron Emission Tomography Study. Stroke, 43, 2610-2616. [Google Scholar] [CrossRef] 
[28] Yoon, H., Oh, H., Lee, H., et al. (2020) Effect of Sevoflurane Postconditioning on the Incidence of Symptomatic Cerebral Hyperperfusion after Revascularization Surgery in Adult Patients with Moyamoya Disease. World Neurosurgery, 134, e991-e1000. [Google Scholar] [CrossRef] [PubMed]
[29] Jo, W., Oh, H., Kim, H., et al. (2020) Preoperative Platelet Count May Predict Postoperative Symptomatic Cerebral Hyperperfusion Syndrome after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis in Moyamoya Patients. Clinical Neurology and Neurosurgery, 199, Article ID: 106260. [Google Scholar] [CrossRef] [PubMed]
[30] Hayashi, T., Kimiwada, T., Karibe, H., et al. (2021) Preopera-tive Risks of Cerebral Infarction in Pediatric Moyamoya Disease. Stroke, 52, 2302-2310. [Google Scholar] [CrossRef] 
[31] Roder, C., Haas, P., Fudali, M., et al. (2020) Neuropsy-chological Impairment in Adults with Moyamoya Angiopathy: Preoperative Assessment and Correlation to Mri and H2 15O PET. Neurosurgical Review, 43, 1615-1622. [Google Scholar] [CrossRef] [PubMed]
[32] Agarwal, V., Singh, P., Ahuja, C., et al. (2021) Non-Invasive Assessment of Cerebral Microvascular Changes for Predicting Postoperative Cerebral Hyperperfusion after Surgical Re-vascularisation for Moyamoya Disease: An Arterial Spin Labelling MRI Study. Neuroradiology, 63, 563-572. [Google Scholar] [CrossRef] [PubMed]
[33] 翟明玉, 王勇, 吴丽敏, 杨佳, 韩明明, 黄祥, 李娟. 多模式监测对缺血型烟雾病血管重建术患者术后恢复的影响[J]. 临床麻醉学杂志, 2020, 36(7): 629-633.
[34] 孙彦熙, 步星耀, 袁强, 闫兆月, 马春晓, 屈鸣麒, 杨冬谊, 张慧. 联合血管重建术配合辛伐他汀治疗缺血型烟雾病的临床研究[J]. 中华脑科疾病与康复杂志, 2015, 5(1): 10-14.
[35] Kanamori, F., Araki, Y., Yokoyama, K., et al. (2021) Effects of Aspirin and Heparin Treatment on Perioperative Outcomes in Patients with Moyamoya Disease. Acta Neuro-chirurgica, 163, 1485-1491. [Google Scholar] [CrossRef] [PubMed]
[36] Liu, X., Zhang, D., Wang, S., et al. (2015) Clinical Features and Long-Term Outcomes of Moyamoya Disease: A Single-Center Experience with 528 Cases in China. Journal of Neuro-surgery, 122, 392-399. [Google Scholar] [CrossRef] 
[37] Huang, Z., Ding, X., Men, W., Zhang, D., et al. (2015) Clinical Features and Outcomes in 154 Patients with Haemorrhagic Moyamoya Disease: Comparison of Conservative Treatment and Surgical Revascularization. Neurological Research, 37, 886-892. [Google Scholar] [CrossRef] 

为你推荐